BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9347391)

  • 1. The efficacy and acceptability of amineptine versus fluoxetine in major depression.
    Dalery J; Rochat C; Peyron E; Bernard G
    Int Clin Psychopharmacol; 1997 Jul; 12 Suppl 3():S35-8. PubMed ID: 9347391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind comparison of moclobemide and amineptine in the treatment of depressed out-patients.
    Macher JP; Mirabaud C
    Psychopharmacology (Berl); 1992; 106 Suppl():S116-7. PubMed ID: 1546123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine versus amineptine in the treatment of outpatients with major depressive disorders.
    Ferreri M
    Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():97-101. PubMed ID: 2644344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study of the efficacy and acceptability of amineptine and fluoxetine in patients with major depression].
    Dalery J; Rochat C; Peyron E; Bernard G
    Encephale; 1992; 18(3):257-62. PubMed ID: 1299597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoxetine dependence in a former amineptine abuser.
    Taïeb O; Larroche C; Dutray B; Baubet T; Moro MR
    Am J Addict; 2004; 13(5):498-500. PubMed ID: 15764428
    [No Abstract]   [Full Text] [Related]  

  • 6. Amineptine in the management of the depressive syndromes.
    Scarzella L; Scarzella R; Mailland F; Bergamasco B
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):429-39. PubMed ID: 4070645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of amineptine in the treatment of depressive patients with irritable bowel syndrome.
    Alevizos B; Christodoulou GN; Ioannidis C; Voulgari A; Mantidis A; Spiliadis C
    Clin Neuropharmacol; 1989; 12 Suppl 2():S66-76. PubMed ID: 2698273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoxetine versus amitriptyline in the treatment of major depression with associated anxiety (anxious depression): a double-blind comparison.
    Versiani M; Ontiveros A; Mazzotti G; Ospina J; Dávila J; Mata S; Pacheco A; Plewes J; Tamura R; Palacios M
    Int Clin Psychopharmacol; 1999 Nov; 14(6):321-7. PubMed ID: 10565798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of amitriptyline and amineptine in patients affected by anxious depression.
    Rampello L; Nicoletti G; Raffaele R; Drago F
    Neuropsychobiology; 1995; 31(3):130-4. PubMed ID: 7609861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine (prozac) in depresion of adults.
    Kocur J; Rydzynski Z; Duszyk S; Gruszczynski W; Trendak W
    Homeost Health Dis; 1991; 33(5-6):295. PubMed ID: 18265505
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined cognitive-behavioral, psychopharmacological and nutritional therapy in eating disorders. 2. Anorexia nervosa--binge-eating/purging type.
    Brambilla F; Draisci A; Peirone A; Brunetta M
    Neuropsychobiology; 1995; 32(2):64-7. PubMed ID: 7477801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind trial of amineptine and clomipramine in the treatment of depression.
    Lemoine P; Achaintre A; Balvay G; Bonnet H; Burgat R; Carrier C; Perrin J
    Curr Med Res Opin; 1981; 7(4):234-40. PubMed ID: 7014104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
    Sandor P; Baker B; Irvine J; Dorian P; McKessok D; Mendlowitz S
    Depress Anxiety; 1998; 7(2):69-72. PubMed ID: 9614594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind comparison of fluoxetine and nortriptyline in the treatment of moderate to severe major depression.
    Akhondzadeh S; Faraji H; Sadeghi M; Afkham K; Fakhrzadeh H; Kamalipour A
    J Clin Pharm Ther; 2003 Oct; 28(5):379-84. PubMed ID: 14632962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of amineptine in the prevention of relapse in unipolar depression.
    Ferreri M; Colonna L; Leger JM
    Int Clin Psychopharmacol; 1997 Jul; 12 Suppl 3():S39-45. PubMed ID: 9347392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is anxious-agitated major depression responsive to fluoxetine? A double-blind comparison with amitriptyline.
    Marchesi C; Ceccherininelli A; Rossi A; Maggini C
    Pharmacopsychiatry; 1998 Nov; 31(6):216-21. PubMed ID: 9930635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoxetine versus trimipramine in the treatment of depression in geriatric patients.
    Wehmeier PM; Kluge M; Maras A; Riemann D; Berger M; Kohnen R; Dittmann RW; Gattaz WF
    Pharmacopsychiatry; 2005 Jan; 38(1):13-6. PubMed ID: 15706460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients.
    Diaz A; Fouilloux C; Ortiz S
    Proc West Pharmacol Soc; 2002; 45():154-5. PubMed ID: 12434564
    [No Abstract]   [Full Text] [Related]  

  • 19. [Amineptine versus imipramine. Double-blind controlled study].
    Oules J; Boscredon J
    Presse Med; 1983 Oct; 12(36):2243-6. PubMed ID: 6226963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.
    Versiani M; Moreno R; Ramakers-van Moorsel CJ; Schutte AJ;
    CNS Drugs; 2005; 19(2):137-46. PubMed ID: 15697327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.